Bacterial Species and Inflammatory Cell Variability in Respiratory Tracts of Patients with Chronic Obstructive Pulmonary Disease Exacerbation: A Multicentric Study

References

• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5). doi:10.1183/13993003.00164-2019
   Web of Science ®Google Scholar
• Bakakos P, Schleich F, Alchanatis M, et al. Induced sputum in asthma: from bench to bedside. Curr Med Chem. 2011;18:1415–1422. doi:10.2174/092986711795328337
   PubMed Web of Science ®Google Scholar
• Armitage MN, Spittle DA, Turner AM. A systematic review and meta-analysis of the prevalence and impact of pulmonary bacterial colonisation in stable State Chronic Obstructive Pulmonary Disease (COPD). Biomedicines. 2021;10(1):81. doi:10.3390/biomedicines10010081
   PubMed Web of Science ®Google Scholar
• Dubourg G, Abat C, Rolain JM, et al. Correlation between sputum and bronchoalveolar lavage fluid cultures. J Clin Microbiol. 2015;53(3):994–996. doi:10.1128/JCM.02918-14
   PubMed Web of Science ®Google Scholar
• Phillips TM, Moloney C, Sneath E, et al. Associated factors, assessment, management, and outcomes of patients who present to the emergency department for acute exacerbation of chronic obstructive pulmonary disease: a scoping review. Respir Med. 2022;193:106747. doi:10.1016/j.rmed.2022.106747
   PubMed Web of Science ®Google Scholar
• Long B, Rezaie SR. Evaluation and management of asthma and chronic obstructive pulmonary disease exacerbation in the emergency department. Emerg Med Clin North Am. 2022;40(3):539–563. doi:10.1016/j.emc.2022.05.007
   PubMed Web of Science ®Google Scholar
• MacLeod M, Papi A, Contoli M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: diagnosis, treatment, prevention and disease impact. Respirology. 2021;26(6):532–551. doi:10.1111/resp.14041
   PubMed Web of Science ®Google Scholar
• Andreas S, Testa M, Boyer L, et al. Non-typeable Haemophilus influenzae-Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial. Lancet Respir Med. 2022;10(5):435–446. doi:10.1016/S2213-2600(21)00502-6
   PubMed Web of Science ®Google Scholar
• Liu J, Ran Z, Wang F, Xin C, Xiong B, Song Z. Role of pulmonary microorganisms in the development of chronic obstructive pulmonary disease. Crit Rev Microbiol. 2021;47(1):1–12. doi:10.1080/1040841X.2020.1830748
   PubMed Web of Science ®Google Scholar
• Zinellu A, Zinellu E, Pau MC, et al. A comprehensive systematic review and meta-analysis of the association between the neutrophil-to-lymphocyte ratio and adverse outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease. J Clin Med. 2022;11(12):3365. doi:10.3390/jcm11123365
   PubMed Web of Science ®Google Scholar
• Waeijen-Smit K, Houben-Wilke S, DiGiandomenico A, Gehrmann U, Franssen FME. Unmet needs in the management of exacerbations of chronic obstructive pulmonary disease. Intern Emerg Med. 2021;16(3):559–569. doi:10.1007/s11739-020-02612-9
   PubMed Web of Science ®Google Scholar
• Millares L, Monso E. The microbiome in COPD: emerging potential for microbiome-targeted interventions. Int J Chron Obstruct Pulmon Dis. 2022;12(17):1835–1845. doi:10.2147/COPD.S371958
   Google Scholar
• Seo H, Sim YS, Min KH, et al. The relationship between comorbidities and microbiologic findings in patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2022;20(17):855–867. doi:10.2147/COPD.S360222
   Google Scholar
• Mussema A, Beyene G, Gashaw M. Bacterial isolates and antibacterial resistance patterns in a patient with acute exacerbation of chronic obstructive pulmonary disease in a tertiary teaching hospital, Southwest Ethiopia. Can J Infect Dis Med Microbiol. 2022;31(2022):9709253.
   Google Scholar
• Kaleem Ullah M, Malamardi S, Siddaiah JB, et al. Trends in the bacterial prevalence and antibiotic resistance patterns in the acute exacerbation of chronic obstructive pulmonary disease in hospitalized patients in South India. Antibiotics. 2022;11(11):1577. doi:10.3390/antibiotics11111577
   Google Scholar
• Beasley V, Joshi PV, Singanayagam A, Molyneaux PL, Johnston SL, Mallia P. Lung microbiology and exacerbations in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:555–569. doi:10.2147/COPD.S28286
   PubMed Web of Science ®Google Scholar
• Liang C, Mao X, Niu H, et al. Characteristics, management and in-hospital clinical outcomes among inpatients with acute exacerbation of chronic obstructive pulmonary disease in china: results from the phase i data of ACURE Study. Int J Chron Obstruct Pulmon Dis. 2021;25(16):451–465. doi:10.2147/COPD.S281957
   Google Scholar
• He ZY, Ou LM, Zhang JQ, et al. Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease. Respiration. 2010;80(6):445–452. doi:10.1159/000321374
   PubMed Web of Science ®Google Scholar
• Ho CG, Milne S, Li X, et al. Airway Eosinophilia on bronchoalveolar lavage and the risk of exacerbations in COPD. Biomedicines. 2022;10(6):1412. doi:10.3390/biomedicines10061412
   PubMed Web of Science ®Google Scholar
• De Nuccio F, Piscitelli P, Toraldo DM. Gut-lung microbiota interactions in Chronic Obstructive Pulmonary Disease (COPD): potential mechanisms driving progression to COPD and epidemiological data. Lung. 2022;200:773–781. doi:10.1007/s00408-022-00581-8
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic pulmonary disease; 2021. Available from: http://www.goldcopd.org/Guidelines/guidelines-resources.html. Accessed April 4, 2023.
   Google Scholar
• Sato M, Chubachi S, Sasaki M, et al. Impact of mild exacerbation on COPD symptoms in a Japanese cohort. Int J Chron Obstruct Pulmon Dis. 2016;9(11):1269–1278.
   Google Scholar
• Graham BL, Steenbruggen I, Miller MR, et al. Standardization of spirometry 2019 update. an official American Thoracic Society and European respiratory society technical statement. Am J Respir Crit Care Med. 2019;200(8):e70–e88. doi:10.1164/rccm.201908-1590ST
   PubMed Web of Science ®Google Scholar
• Shepherd E. Specimen collection 4: procedure for obtaining a sputum specimen. Nurs Times. 2017;113(10):49–51.
   Google Scholar
• Reynolds HY. Bronchoalveolar lavage and other methods to define the human respiratory tract milieu in health and disease. Lung. 2011;189(2):87–99. doi:10.1007/s00408-011-9284-5
   PubMed Web of Science ®Google Scholar
• Lee YJ, Shin S, Roh EY, et al. Acceptability of sputum specimens for diagnosing pulmonary tuberculosis. J Korean Med Sci. 2015;30:733–736. doi:10.3346/jkms.2015.30.6.733
   PubMed Web of Science ®Google Scholar
• Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal. 2016;6(2):71–79. doi:10.1016/j.jpha.2015.11.005
   PubMed Web of Science ®Google Scholar
• Bhattacharya AK. Role of sputum cultures in diagnosis of respiratory tract infections. Lung India. 2006;23:20. doi:10.4103/0970-2113.44426
   Google Scholar
• Baselski V, Klutts JS, Baselski V, et al. Quantitative cultures of bronchoscopically obtained specimens should be performed for optimal management of ventilator-associated pneumonia. J Clin Microbiol. 2013;51:740–744.
   PubMed Web of Science ®Google Scholar
• Maestrelli P, Saetta M, Di Stefano A, et al.Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage. Medicine. 1995;152(6 Pt 1):1926–1931.
   Web of Science ®Google Scholar
• Agnė B, Jolanta J, Rimantas S, et al. The effect of induced sputum and bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease on neutrophil migration in vitro. Medicina. 2010;46(5):315–332. doi:10.3390/medicina46050044
   PubMedGoogle Scholar
• Attaa MSS, Baessa AI, Abdullah MHM. Comparative study between bronchoalveolar lavage and induced sputum in the diagnosis of inflammatory lung diseases. Egypt J Bronchol. 2017;11:81–87. doi:10.4103/ejb.ejb_78_16
   Google Scholar
• Tsoumakidou M, Tzanakis N, Siafakas NM. Induced sputum in the investigation of airway inflammation of COPD. Respir Med. 2003;97(8):863–871. doi:10.1016/S0954-6111(03)00035-0
   PubMed Web of Science ®Google Scholar
• De Serres G, Lampron N, La Forge J, et al. Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol. 2009;46(2):129–133. doi:10.1016/j.jcv.2009.07.010
   PubMed Web of Science ®Google Scholar
• Sharan H. Aerobic bacteriological study of acute exacerbations of chronic obstructive pulmonary disease. J Clin Diagn Res. 2015;9(8):DC10–DC12. doi:10.7860/JCDR/2015/14515.6367
   PubMedGoogle Scholar
• Monso E, Ruiz J, Rosell A, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med. 1995;152(4 pt 1):1316–1320. doi:10.1164/ajrccm.152.4.7551388
   PubMed Web of Science ®Google Scholar
• Wang J, Chai J, Sun L, Zhao J, Chang C. The sputum microbiome associated with different sub-types of AECOPD in a Chinese cohort. BMC Infect Dis. 2020;20(1):610. doi:10.1186/s12879-020-05313-y
   PubMed Web of Science ®Google Scholar
• Leiten EO, Nielsen R, Wiker HG, et al. The airway microbiota and exacerbations of COPD. ERJ Open Res. 2020;6(3):00168–2020. doi:10.1183/23120541.00168-2020
   PubMedGoogle Scholar
• Goolam Mahomed T, Peters RPH, Allam M, et al. Lung microbiome of stable and exacerbated COPD patients in Tshwane, South Africa. Sci Rep. 2021;11(1):19758. doi:10.1038/s41598-021-99127-w
   PubMed Web of Science ®Google Scholar
• Zhu K, Zhou S, Xu A, et al. Microbiota imbalance contributes to COPD deterioration by enhancing IL-17a production via miR-122 and miR-30a. Mol Ther Nucleic Acids. 2020;22:520–529. doi:10.1016/j.omtn.2020.09.017
   PubMedGoogle Scholar
• Han Y, Hua J, He B, Zhang J. Inhaled antibiotics and airway bacterial decolonization for patients with chronic obstructive pulmonary disease: the rationale and future. J Transl Int Med. 2022;10(3):181–184. doi:10.2478/jtim-2022-0005
   PubMed Web of Science ®Google Scholar